B3GNT3 and neoplasm: Consistent with previous oncologic studies about B3GNT3, multiple PC databases indicated that B3GNT3 was notably overexpressed in tumor tissues [12, 16, 24], and positively correlated with tumor size, histologic grade, and poor survival of patients with PC, which indicates that B3GNT3 may be an unfavorable prognostic biomarker for PC.